Faron Pharmaceuticals Corporate Deck

Results

Presentations & Publications

 

DATE TITLE

LINKS

October 22, 2024 Faron Capital Markets Day 2024

Link to the Webcast
Link to the Presentation

October 9, 2024 Proactive One2One Biotech Investor Forum Link to the Webcast
August 27, 2024 Half-Year Financial Results, 1 January - 30 June 2024 A virtual briefing and Q&A session hosted by Dr. Juho Jalkanen, CEO, Yrjö Wichmann, CFO and Dr. Petri Bono, CMO, on the day of results

Link to the Webcast
July 11, 2024 FDA Feedback Update Link to the Presentation
May 22, 2024 BEXMAB Study Update Link to the Presentation
March 19, 2024 BEXMAB Study Update Link to the Presentation
January 11, 2024 J.P. Morgan Healthcare Conference Link to the Presentation
Link to the Presented Deck
December 9-12, 2023 ASH 2023 Annual Meeting Link to the Poster
October 20-24, 2023 ESMO Congress 2023 Link to the Poster
September 12, 2023 H.C. Wainwright 25th Annual Global Investment Conference - September 11-13, 2023 Link to the Webcast
August 29, 2023 Half-Year Financial Results for the Six Months Ended June 30, 2023

Link to the Webcast

Link to the Presentation

August 10, 2023 Faron Participation at Canaccord Genuity 43rd Annual Growth Conference Link to the Presentation
July 19, 2023 BEXMAB Study Update

Link to the Presentation

Link to the Webcast

May 31, 2023 European Hematology Association Meeting 2023 - Poster Link to the Poster
April 25, 2023 Bexmarilimab for Hematological Malignancies KOL Event
Link to the Recording
March 3, 2023 Faron Financial Statement 2022 Webcast

Link to the Webcast
December 13, 2022 Faron as an Investment | Company Night Dec. 13, 2022

Link to the Webcast
November 28, 2022 Redeye Life Science Day 2022

Link to the Q&A

Link to the Prerecorded Video
September 21, 2022 Faron to Host Bexmarilimab Update Webcast

Link to the Webcast
September 13, 2022 Pörssisijoittajan viikko - Faron sijoituskohteena Toimitusjohtaja Markku Jalkasen esitys katsottavissa linkistä
September 12, 2022 H.C. Wainwright 24th Annual Global Investment Conference - September 12-14, 2022 On-demand presentation is available starting Monday, 
Sep 12, 2022 at 7:00 am EDT / 12:00 pm GMT / 2:00 pm EET
August 25, 2022 Half-Year Financial Results for the Six Months Ended June 30, 2022

A virtual briefing and Q&A session hosted by Dr. Markku Jalkanen, CEO, and Toni Hänninen, CFO, on the day of results
Link to the Presentation
Link to the Webcast